Table 1. Demographic and clinical characteristics of the patients (N = 97).

Study variables	n (%)
Age group
≤20 years	21 (21.6%)
21–23 years	45 (46.4%)
>23 years	31 (32.0%)
Gender
Male	30 (30.9%)
Female	67 (69.1%)
Weight (n = 83)
30–50 kg	17 (20.5%)
51–70 kg	42 (50.6%)
>70 kg	24 (28.9%)
Age of acne onset
11–15 years	19 (19.6%)
16–19 years	31 (32.0%)
>19 years	47 (48.5%)
Age at which isotretinoin treatment began
≤20 years	48 (49.5%)
21–23 years	35 (36.1%)
>23 years	14 (14.4%)
Starting dose
10–20 mg	85 (87.6%)
30–40 mg	12 (12.4%)
Ending dose
10–20 mg	43 (44.3%)
30–40 mg	49 (50.5%)
>40 mg	5 (5.2%)
Duration of treatment
<5 months	52 (53.6.%)
≥5 months	45 (46.4%)
Previous isotretinoin use
Yes	7 (7.2%)
No	90 (92.8%)